Summary

• Graduate Ventures has launched a €125 million seed fund with €100 million already committed.
• Its network spans eight Dutch universities and three university medical centres.
• More than 200 entrepreneurs and alumni support founders alongside the investment team.

Dutch investment platform Graduate Ventures has launched a €125 million second seed fund, expanding a model that connects university founders with venture capital and a network of entrepreneurs who have already built technology businesses.

The vehicle has secured €100 million of commitments. Backers include former Snowflake chief Frank Slootman, Picnic founder Michiel Muller, DataSnipper co-founder Jonas Ruyter and former ASML chief executive Peter Wennink, while public investors Invest-NL and Oost NL are also participating.

Graduate Ventures now works with eight universities and three university medical centres across the Netherlands. Its funds invest in areas including AI, deep tech, healthcare and climate, with academic ecosystems rather than one narrow technology category providing the common thread.

That structure distinguishes the fund from a conventional European technology vehicle. University relationships give Graduate Ventures access to researchers and new companies, while a network of more than 200 entrepreneurs and alumni adds commercial experience after an investment has been made.

Research needs more than a cheque

Universities can produce valuable intellectual property and technically ambitious founders without automatically providing everything needed to build a company. Researchers moving towards commercialisation encounter decisions around ownership, recruitment, customers, product development and later financing while continuing to manage the relationship with the institution where the technology originated.

Graduate Ventures places experienced operators closer to that transition. Founders can draw on people who have raised capital, hired teams and entered international markets rather than relying entirely on the investment professionals administering the fund.

The network has expanded from its original connections with Delft University of Technology and Erasmus University Rotterdam into a national footprint covering more academic ecosystems. That gives the fund a broader pipeline while reducing dependence on whichever investors happen to be concentrated around one university city.

The model has already produced more than 90 investments, according to Graduate Ventures. One early portfolio company is Delft quantum computing business QuantWare, which received backing from the organisation in 2021 and later raised a €152 million Series B.

QuantWare does not prove that the rest of the portfolio will follow the same trajectory, but it illustrates the financing path faced by research intensive businesses. A small university linked investment can help a company form, while later technical development may require capital measured in tens or hundreds of millions of euros.

A national network faces a scale test of its own

The new fund increases both the amount of capital available and the number of institutions feeding companies into the network. That expansion can create more opportunities, but it also broadens the range of technical expertise the investment organisation needs around its portfolio.

AI software, quantum hardware, healthcare and climate technology do not share identical development cycles, customers or regulatory requirements. Graduate Ventures’ answer is to draw on its extended alumni and entrepreneur network rather than attempt to employ every relevant specialist inside a conventional venture team.

Around 20 students also work with the organisation each year, creating another connection between the fund and its partner universities while giving future founders and investors exposure to venture activity.

The €125 million vehicle still operates at the early end of the funding market. It cannot replace the larger international investors required when capital needs expand significantly, particularly for hardware and life sciences businesses.

Its value instead lies in helping more companies reach the stage where those later investors can engage. Research based founders often need support before a company has the commercial metrics conventional venture funds prefer, especially when technical validation precedes meaningful revenue by several years.

The Netherlands already has a strong technology ecosystem, but research quality alone does not guarantee that companies remain in the country or reach international scale. Capital, management experience and access to commercial networks influence whether intellectual property develops into a durable business.

Graduate Ventures is trying to make those resources available through one national university network rather than leaving each institution to build its own complete investment ecosystem. That can reduce duplication while giving founders outside the best connected centres access to people and capital from elsewhere.

The second seed fund now has to show that a larger network does not weaken those relationships. More universities and more capital increase the opportunity set, but useful founder support depends on whether the relevant expertise remains accessible when a company encounters a specific technical or commercial problem.

With €100 million already committed towards the €125 million target, Graduate Ventures has substantial backing for the model. Its next test is not whether Dutch universities can produce promising research, but whether connecting those institutions through one investment and operator network helps more of that research survive the difficult transition into companies capable of attracting international capital.